A New Era of Innovation and Patient Care
When & Where
Impact of Digital Velocity on Healthcare
Three years into the pandemic, there is a new world order for the healthcare industry. Disruption is coming everywhere - Big Tech, Vertical Integration, Regulation, Reimbursements, Supply Chains, Labor Costs, Clinician Shortage & Burn Outs, and now ChatGPT. What is needed to drive future innovation in the healthcare industry and handle whatever comes next? The answer increasingly lies in automation with new solutions like generative AI leveraging torrents of Data collected from patients, payers, machines, and facilities. This new world demands a different approach to this complex ecosystem, data from many places, helping people make choices, promoting consumer engagement, and providing insights. Attend this insightful track to learn from industry leaders, tech experts, and entrepreneurs about this new, high-touch, high-tech ecosystem in which data flows freely and delivers more precise insights for patients, providers, and the health system.
Track Agenda
- 05/04/2023 | 2:00 pm – 2:15 pm PDT
- 15 minsSpeakers
Bridget KarlinSVP IT Operations
Kaiser PermanenteBridget Karlin is the senior vice president, Information Technology, Services & Operations, at Kaiser Permanente, a $95 billion healthcare business. In her role at one of the largest integrated healthcare institutions in the world, with more than 88,000 physicians and nurses to provide care to 12.6 million members, Karlin is responsible for the information technology, services and operations that power Kaiser Permanente’s business. She is redefining how services are delivered to patients, members, employees, and partners, by transforming to an AI-based, automated, and secure IT shared services model that is enabling enterprise-wide digital transformation. Karlin leads the strategy, development, and services for a hybrid, multi-cloud enterprise IT environment, including platforms, network, infrastructure, application support, disaster and cyber resiliency, workplace technologies, and end-user services.
Karlin leverages artificial intelligence, automation, security, cloud, and open-source technologies to enhance care delivery, strengthen resiliency, ensure compliance, and for modernizing offerings and capabilities across applications and infrastructure environments. She defines the technology vision, sets the strategy, and provides the technical leadership that drives collaboration, keeping Kaiser Permanente at the forefront of the industry by building technical communities with developers and strategic ecosystem partners to flourish in thought leadership, new ways of working, and innovation for a more compelling healthcare experience.
Prior to Kaiser Permanente, Bridget served as IBM’s Global Chief Technology Officer of the $20 billion Global Technology Services division. In this role, she was responsible for the industry’s largest IT Infrastructure services estate of more than 750,000 servers supporting millions of endpoints from the edge to the cloud, with a global team of distinguished engineers, data scientists, and advanced architects. As global CTO, her notable innovation with AI-based automation across private and public cloud environments earned IBM the industry leadership ranking for Intelligent IT Infrastructure Services Automation, while delivering key operating results.
Before joining IBM, Karlin held senior leadership roles at Intel Corporation, as general manager of its Internet of Things division, and prior to that, as general manager of Intel’s Hybrid Cloud business. Additionally, she has served in executive positions at Union Bank, managing director at Redleaf Venture Capital, and was president and co-founder of Thinque Systems, a pioneer in mobile software deployed in 43 countries.
Karlin serves on the board of Dana Inc. (NYSE: DAN), a Fortune 500 world leader in automotive manufacturing for conventional, hybrid, and electric-powered vehicles. Additionally, she serves on the board of the Consumer Technology Association (CTA), a non-profit organization that represents the $398 billion U.S. consumer technology industry. Karlin is a recipient of the 2021 Technology Hall of Fame, the 2019 National Technology Humanitarian Award, the 2019 Women in Consumer Technology Legacy Award, the Industrial IoT 5G Innovators Award, the Malcolm Baldrige National Quality Award, and the Bell Labs Technology Innovator Award.
-
- 05/04/2023 | 2:15 pm – 3:00 pm PDT
- 45 mins Hall A2Speakers Tarannum Guller, MD, chief medical officer, is an Internal Medicine trained, career hospitalist, most recently serving as a senior executive providing hospitalist and intensivist services across California and the country. Dr. Guller received her medical degree from the Pravara Institute of Medical Science, India and completed her residency at Newton-Wellesley Hospital, Boston, Massachusetts. She has a Masters in Medical Management from Carnegie Mellon University and was Chief Resident for her residency program. Dr. Guller is patient centric and brings a passion for world-class quality and service. She has worked both for profit and not for profit as well as non profit healthcare entities. She was recently honored by Silicon Valley Business Journal at their Women of Influence event for her work during the COVID pandemic in the county of Santa Clara. Sara VaezyEVP Chief Strategy and Digital Officer
Providence HealthSara Vaezy is Executive Vice President and Chief Strategy and Digital Officer for Providence where she is responsible for system strategy and digital innovation for the integrated delivery network (IDN) which includes 52 hospitals and 1,085 clinics and serves over 5 million unique patients. Sara brings deep experience to the organization in both digital and enterprise strategy development and leads system strategy, the ongoing development and evolution of Providence’s integrated strategic and financial plan and cross-collaboration of the Providence councils as Providence continues to advance toward and design the system of the future. Sara is the architect of the Providence digital innovation model upon with the Digital Innovation Group (DIG) was founded, resulting in company partnerships and incubation of technologies that deliver value for Providence as well as other health systems. Sara is active in the broader healthcare industry serving as an NCQA Board Director, as a member of inaugural class of the Frist Cressey Ventures Collective, a Harvard Executive Education Faculty Member, a Health Evolution Forum Fellow, World 50 Digital 50 member, a Forbes Business Council Member, and a board observer for DexCare. She has won numerous awards and has been recognized as a Business Insider 30 under 40 Transforming the Future of Healthcare (2019), Catholic Health Association Tomorrow’s Leader (2019), a Becker’s Rising Star in Health IT (2020), and a Becker’s Women to Watch in Health IT (2020 & 2022). She holds an MHA and an MPH in Health Policy from the University of Washington School of Public Health and BAs in Physics and Philosophy from the University of California, Berkeley. Dr. Peter FitzgeraldMD, Founder and Investor
Tri VenturesDr. Peter Fitzgerald is Director of the Center for Cardiovascular Technology at Stanford University Medical School, and Co-founder/Managing Partner at Triventures. He is an Interventional Cardiologist and has a PhD in Engineering. He is Professor Emeritus in the Departments of Medicine and Engineering at Stanford. He has led or participated in over 150 clinical trials, published over 450 manuscripts/chapters, and lectures worldwide. Peter has been principle/founder of 24 healthcare companies in Silicon Valley, has transitioned 18 of these start-ups to medium/large-cap life science companies and remains on several of their advisory boards. He has been a consultant for the FDA for the past 15 years focused on medical technology and more recently, digital health. Prior, Peter was a co-founding partner of LVP capital in San Francisco, deriving his experience in venture capital from three funds focused on medical device and biotechnology start-ups. Peter is co-founder and managing partner of Triventures and heads the US office. Peter currently participates on the boards of: Cala Health, Cathworks, Day Zero Diagnostics, FemSelect, Genoox, HealthReveal, V-wave. Past Triventures’ portfolio companies where Peter participated on the boards include: Apica, MST, Orthospace and Zingbox.
-
- 05/04/2023 | 3:00 pm – 3:30 pm PDT
- 30 mins Hall A2Speakers Marcus ZacharyChief Clinical Officer
Babylon HealthDr. Marcus Zachary is a physician executive specializing in population health. He currently works at Babylon Health as the Chief Clinical Officer overseeing US operations. Prior to being in operations, he served as the Global Head of Business Development working broadly with product, clinical, operations and sales to deploy this first of its kind virtual primary care model. Before joining Babylon, Dr Zachary was the Associate CMO and National Medical Executive for Payer Partnership Solutions at Evolent Health. He provided clinical support and oversight for all activities occurring in the solution. This included but was not limited to business development, clinical implementation, medical analytics and ongoing operations. Marcus also provided a California IPA lens to organizational efforts around HCC/RAF, clinical analytics, quality and physician compensation. Prior to joining Evolent, Dr. Zachary was the VP/Senior medical director for quality and population health at Brown and Toland Medical Group. He was responsible for the strategic goals of BTMG with particular focus on ACOs and other risk products. He also had direct operational oversight of the medical services organization and performance improvement departments. Within the organization, Dr. Zachary helped design and drive initiatives linking quality, utilization, and IT in the pursuit of the Triple Aim. Prior to joining BTMG, Dr. Zachary was the lead physician informaticist for Dignity Health in San Francisco. He oversaw the implementation of their hospital electronic medical records system (Cerner). Dr. Zachary served as a Medical Director for both Cogent-HMG and Galen Inpatient Physicians for their respective Hospital Medicine Programs. He is board certified in internal medicine with over a decade of clinical experience as a hospitalist and is a Fellow of the Society of Hospital Medicine. Brigitte Piniewski (Moderator)Physician AuthorWealthcare: Demystifying Web3 and the Rise of Personal Data Economies Brigitte PiniewskiPhysician Author
Wealthcare: Demystifying Web3 and the Rise of Personal Data EconomiesBrigitte Piniewski is a physician, ex-healthcare executive, researcher, author, and angel investor with deep expertise in many angles of healthcare. While providing investor education in Web3 ethos, she has articulated an urgent need for health transformation and the pivotal achievements that these new technological approaches are poised to produce. To this end, Dr Piniewski advises for Nex Cubed, a leader in early-stage innovation and start-up acceleration. She has worked with international founders from Singapore, Korea, and Canada as well as the United States. Dr Piniewski received her medical degree from the University of British Columbia and McGill University, Canada and she currently resides in Portland, Oregon. Author of “Wealthcare: Demystifying Web3 and the Rise of Personal Data Economies” We’re on the cusp of our next leap in global value creation. Just as the industrial age followed by the internet age saw a huge leap in capital and wealth creation, the conditions are set for another leap in wealth. Back then, new, online-enabled tools provided industry with the path to extend traditional businesses models with digitally native solutions and wealth creation soared. Now the core enablers of this next wealth inflection are ready. Of note, this wealth will not be the product of a handful of unicorns, but instead the product of mass consumer participation in robust economies driven by diverse data marketplaces. Wealthcare: Demystifying Web3 and the Rise of Personal Data Economies sets out the why, where, and how stakeholders are organizing in preparation of this next leap in global value creation. What does the future look like? How do we get there? Regardless of where you are in your blockchain and crypto journey, Wealthcare will walk you through the bits needed to both understand and participate in this new tomorrow. We’re excited to have you join the effort. Please invite your friends. Dr. Reena Bhargava, MD, FACP, is a practicing Internist with Board certifications in Internal Medicine, Clinical Informatics, and Lifestyle Medicine. Reena is the Medical Director of Kaiser’s Appointment & Advice Call Center which serves over 4 million patients with their telehealth needs. Reena also serves as a Councilor on the Santa Clara County Medical Association.Reena is passionate about building efficient, clinically safe patient care systems for telehealth, supported by innovative digital technologies. She has been a lead physician for developing clinical decision support tools for Kaiser’s telehealth platform. This platform uses data driven, evidence-based medicine to provide safe, efficient and excellent patient care. Reena has also developed many innovative digital care-delivery tools, including electronic physician visits (e-Visits). Her work on e-Visits and their efficacy has been published in the prestigious publication, JAMA. Reena is a researcher and has published extensively in leading medical journals. Earlier in her career she trained at Stanford University School of Medicine as an NIH Fellow in Endocrinology with a focus on Insulin Resistance and Metabolic Syndrome. From 2006 to 2015, she was a Clinical Assistant Professor (Affiliated) of Medicine at Stanford. Reena is also a leader in women’s health, developing a Healthy Bones program to screen some hundreds of thousands of women for osteoporosis. She has presented her research on osteoporosis, gender bias in lipid management, and domestic/intimate partner violence at International and National Medical conferences.
-
- 05/04/2023 | 3:30 pm – 4:00 pm PDT
- 30 mins Hall A2Speakers Daniel HadersCo-Founder and CEO
Model MedicinesDr. Haders has 20+ years of experience in healthcare as a scientist, entrepreneur, advisor & investor. Dr. Haders is currently the Co-Founder and CEO of Model Medicines, a PIND stage AI/ML Drug Discovery company that has built a pipeline of novel acting broad-spectrum antiviral, oncology and GI assets (https://www.modelmedicines.com/pipeline), including the potential best-in-class, first-in-class MDL-001. More information about MDL-001 and the oncology program can be found here (https://www.modelmedicines.com/newsroom). Model Medicines has raised over $8M to date with backing from investors including 8VC, Friedman Bioventures, Irving Ventures and ParticleX. Prior to co-founding Model Medicines, Daniel launched the Nex Cubed Digital Health Accelerator. Here, Daniel built an early-stage investment portfolio of 25+ Digital Healthcare companies with an enterprise value of over $250M, investment results that would place the portfolio in the top decile. The accelerator has been named one of the Top Ten Global Digital Health Accelerators and The Best Accelerators & Incubators for FemTech Startups. He is also an Operating Partner at Sway Ventures, leading Digital Health investing and portfolio oversight. Dr. Haders is a Board Observer at AppliedVR, a VR digital therapeutic company, backed by investors including F-Prime, Jazz, SVB, JJDC and Sway, which was granted break though device designation and cleared by the FDA in 2022. Other investments include MedCrypt, which recently closed its Series B with co-investors including Dexcom, JJDC, Intuitive Ventures, and Section 32 among others. Dr. Haders is a Faculty Member and Member of the Advisory Committee of the UCSD, Digital Health Certificate Program and a Member of the BioMedX Oversight Committee at Columbia University Technology Ventures. Prior to his current roles, Dr. Haders held positions from research fellow to senior scientist to Co-Founder/CEO in the fields of medical devices, pharmaceuticals & nano-drug delivery. At LuxBio, Daniel and Model Medicines Co-Founder Sean Russell helped develop LX214 from concept through a successful Phase I study. The LX214 program/formulation was further developed clinically by Sun Pharma & gained FDA approval under the name CEQUA in 2018. Dr. Haders holds both a BS and PhD in Biomedical Engineering and has been awarded multiple Fellowships for scientific research including a National Science Foundation IGERT Fellowship in Integratively Engineered Biointerfaces and a Department of Education GAANN Fellowship in Molecular, Cellular and Nanosystems Bioengineering. Ms. Longmore-Grund is a global "C" level executive with deep strategic, operational and financial leadership experience across a variety of company profiles ranging from public and private Fortune 100, mid cap, PE and venture-funded startups. She has significant capital markets experience, leading 30+ transformational M&A and capital formation transactions with ~ $3.5B of value and building high performing leadership teams who successfully deliver sustainable growth and shareholder value. Ms. Longmore-Grund served as President, Chief Executive Officer and Director of Alliance HealthCare Services from 2018 to 2021. When Alliance was acquired in September of 2021 by Akumin Inc. (NASDAQ: AKU), Ms. Longmore-Grund served as President and Co-CEO as well as Director of the newly merged Akumin company to facilitate a smooth transition and integration through March of 2022. With the acquisition of Alliance HealthCare Services, Akumin became the leading provider of comprehensive radiology and oncology healthcare services, operating ~200 fixed site outpatient imaging and radiation therapy centers, providing outsourced services to over 1,000 hospital partners and locations across 46 states and caring for approximately 2M patients per year. Prior to serving as CEO, Ms. Longmore-Grund served in a variety of financial executive roles. She served as Executive Vice President & Chief Financial Officer of Alliance HealthCare Services (NASDAQ: AIQ), Senior Vice President and Chief Financial Officer for Printronix, a global provider of industrial print technology solutions serving Fortune 500 customers across 100 countries in mission critical manufacturing and supply chain applications. She has also served as the Chief Financial Officer of Velocium, now a Northrop Grumman company. Omid TolouiVP of Innovation
Elevance Health & Carelon Digital PlatformsOmid Toloui is the Vice President of Innovation at Elevance Health, where his team reinvents healthcare by identifying, incubating, and implementing innovative solutions to today’s most urgent challenges. Under Omid’s leadership the team has become a catalyst for impact, partnering with business and technology leaders and visionary startups to help Elevance Health improve the health of the more than 119 million people it serves. Prior to his current role, Omid was the Vice President of Digital Health at CareMore & Aspire Health, a subsidiary of Elevance Health focused on innovative care delivery. Omid earned his Master of Business Administration, Master of Public Health in Health Services Management, and Bachelor of Science in Psychobiology from UCLA, where he is also on the faculty of the UCLA Anderson School of Management. Tim KuruvillaSVP, Global Head of Commercialization
RocheTim has a diverse and proven track record of success as an entrepreneur, corporate executive, private equity investor and strategy consultant. Tim is a mission-driven leader with an ability to build, inspire and lead high performing teams. Tim is currently the SVP, Global Head of Commercialization for Roche Information Solutions. In that capacity he leads the end-to-end commercialization of a digital health portfolio which includes workflow, analytics, clinical decision support solutions across oncology, cardiometabolic and neurodegenerative disease areas. Prior to Roche, Tim was a co-founder and Chief Commercial Officer at Viewics, which was acquired by Roche in 2017. Viewics was a healthcare analytics platform which became a market leader in clinical and operational analytics for laboratories. Prior to Viewics, Tim was a founding member of the Applied Technology Investing Team at Opus Capital. He began his career at Stockamp & Associates (Acquired by Huron) leading revenue cycle and patient progression projects at leading academic medical centers and health systems across the U.S. Tim holds a bachelor of Management Science, with honors, from the University of California, San Diego and an MBA from the University of California Haas School of Business with a focus on healthcare.
-
- 05/04/2023 | 4:00 pm – 4:30 pm PDT
- 30 mins Hall A2Speakers Bradd BusickSVP and CIO
MultiCare Health SystemBradd Busick is the SVP and CIO of MultiCare Health System. Previously as the CTO of MultiCare Health System, Bradd was responsible for technology development systems, processes, overall software, and solution design at the company. Bradd has also held high-profile roles at MacDonald-Miller and the Bill and Melinda Gates Foundation, among others. A Business Transformation 150 award winner and TED Speaker, he earned a bachelor’s degree in political science and business administration from Pacific Lutheran University. Bradd also earned his MBA in technology and Innovation Management from Pacific Lutheran University. As senior vice president, and chief Sales and Marketing officer, Satrajit Misra is responsible for overseeing sales and marketing and is responsible for the performance, strategy, and alignment of the booking and revenue growth and development of the U.S. market. Prior to this position, Misra has served as vice president, Marketing, and senior director, CT Business Unit, increasing sales and launching new products including the award-winning Aquilion™ ONE ViSION. Before joining Canon Medical Systems USA, Misra served as senior director and head of product marketing for Nuclear Medicine at Philips Healthcare and was a medical systems director of Business Management at Siemens. With over 25 Years of industry Experience in Multi-modality Medical Imaging & Informatics solutions, Misra holds degrees in applied physics and electrical engineering from the University of Calcutta in India and has attended the School of Business and Economic Studies at the University of Leeds in the United Kingdom. Atif ChaughtaiHead of Global Heathcare & Life sciences
RedhatAtif Chaughtai brings 20+ years experience in information technology with a focus on Healthcare and Life Sciences. At Red Hat, Chaughtai oversees the healthcare vertical solutions, ensuring both industry business needs and emerging requirements align to the Red Hat portfolio. He is an active participant on various Healthcare and Life Sciences standards committees. Prior to joining Red Hat, Chaughtai held positions in healthcare IT as Chief Technologist and Healthcare Ecosystem Executive, including running P&L for a global software organization. At the National Institutes of Health (NIH), Chaughtai served as an Enterprise Architect. His work at NIH included streamlining grants management and clinical research programs while ensuring HIPAA compliance. He was recognized multiple times for his contribution to the NIH’s mission. Chaughtai has two patents for his work in information delivery in low latency and low bandwidth environments.
-
Track Chairs
Dwight French is a proven executive with over 20 years of successful business leadership and experience in the health insurance, provider, and life science sectors. His work serving healthcare includes executive positions at BearingPoint (formerly KPMG Consulting), SVP of Enterprise Product Management at HMS Holdings Corp (HMSY-US), Chief Business Development Officer at Santa Clara County IPA (SCCIPA), and co-founder of a population health management software company that a Fortune 20 strategic invested in and was successfully exited.
Dwight has been working at the leading edge of healthcare reform since its inception. Described as an insightful leader, his innovative strategies exploit business opportunities that arise from this evolving reform. Dwight possesses the rare ability to craft policies and shape vision into actionable results. He accomplishes this unique skill through developing leaders, solid operational execution, effective communication, and intentional relationship development. He now serves as a Healthcare Principal in the Global Healthcare practice for Red Hat.
Red Hat provides transformative digital capabilities that improve flow, reduce friction, and toil inherent in monolithic IT—the abilities required to transcend the cloud-native paradigm shift. As the healthcare ecosystem and health IT gets more complicated, with more specialized outside applications, we have to create a new technology system in which data flows freely and delivers more insights for patients, providers, and the health system across the health ecosystem.
Glassbeam
TiEcon 2023 Tracks
- AI/ML
- Cloud/Edge
- Cybersecurity
- Climate Tech
Climate Tech
The Scope, Technologies and Opportunities in Climate Change
- Global Connect
GLOBAL CONNECT
Expanding entrepreneurial and technological networks across the globe
- Generative AI
- Healthcare
Healthcare Disruption: Redefining the Future
A New Era of Innovation and Patient Care
- Manufacturing
- Rocketship India
Rocketship India
Riding the wave of India's Tech Revolution
- Supply Chain
Supply Chain
Transforming the supply chain to be smart & sustainable for the digital age volatility & complexity
- Web3 & Metaverse
Web3 & Metaverse
Where Web3 & Metaverse technology meets the future of business and innovation.
-
AI/ML
AI/ML: Latest Advances in Artificial Intelligence
-
Cloud/Edge
Creating the AI future on Cloud & Edge
-
Cybersecurity and Compliance
Defending Our Digital Lives
-
Climate Tech
The Scope, Technologies and Opportunities in Climate Change
-
GLOBAL CONNECT
Expanding entrepreneurial and technological networks across the globe
-
Generative AI
The Next Frontier: Generative AI
-
Healthcare Disruption: Redefining the Future
A New Era of Innovation and Patient Care
-
Next-Gen Manufacturing
Riding the Waves of Disruption
-
Rocketship India
Riding the wave of India's Tech Revolution
-
Supply Chain
Transforming the supply chain to be smart & sustainable for the digital age volatility & complexity
-
Web3 & Metaverse
Where Web3 & Metaverse technology meets the future of business and innovation.